<DOC>
	<DOCNO>NCT00151515</DOCNO>
	<brief_summary>The primary purpose study evaluate efficacy topical 5 % minoxidil formulation male treatment pattern hair loss . The secondary purpose evaluate safety topical 5 % minoxidil formulation male use twice daily treatment pattern hair loss obtain safety data investigational product use twice daily one year .</brief_summary>
	<brief_title>A Study Evaluate Effectiveness Safety 5 Percent Minoxidil Foam Treatment Male Pattern Hair Loss</brief_title>
	<detailed_description>Male subject androgenetic alopecia enrol fourteen-center trial . Subjects randomize use either 5 % minoxidil placebo foam twice daily 16 week . A total 143 subject continue use 5 % minoxidil foam 8 12 month open-label phase obtain safety data 5 % minoxidil topical foam use twice daily one year . The 5 % minoxidil foam show effective treatment male androgenetic alopecia 16 week trial . It statistically significantly superior placebo foam primary efficacy measure mean change non-vellus hair count target region Baseline Week 16 , subject rating assess overall improvement Baseline . The efficacy 5 % minoxidil compare placebo confirm secondary efficacy endpoint score expert panel review hair regrowth compare photograph obtain Baseline photograph obtain Week 16 , well percent change Baseline non-vellus hair count within pre-specified area clip hair . The 5 % minoxidil foam formulation well tolerate , incidence adverse event similar group , safety concern raise base clinical laboratory test result , vital sign scalp irritation score .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Minoxidil</mesh_term>
	<criteria>presence androgenetic alopecia vertex pattern IIIv , IV , V Norwood Hamilton Scale Male sex , age 15 49 , good health Willingness dot tattoo place target area scalp study Willingness maintain normal shampoo habit product study Willingness maintain hair style , approximate length , hair color throughout study Known sensitivity investigational product</criteria>
	<gender>Male</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Alopecia , Balding</keyword>
</DOC>